1. Sequential treatment with afatinib and osimertinib in real-world patients with EGFR mutation-positive advanced NSCLC: the GioTag study. (January 2019) Authors: Hochmair, M.; Cufer, T.; Morabito, A.; Hao, D.; Ta Yang, C.; Soo, R.; Yang, J.; Gucalp, R.; Halmos, B.; Wang, L.; Golembesky, A.; Märten, A.; O'Byrne, K. Journal: Lung cancer Issue: Volume 127(2019)Supplement 1 Page Start: S59 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗